Matthew McCarthy1, Charlotte L Edwardson, Melanie J Davies, Joseph Henson, Laura Gray, Kamlesh Khunti, Thomas Yates. 1. 1Department of Health Sciences, University of Leicester, Leicester, Leicestershire, UNITED KINGDOM; 2Leicester-Loughborough Diet, Lifestyle and Physical Activity Biomedical Research Unit, National Institute for Health Research (NIHR), Loughborough, UNITED KINGDOM; 3Diabetes Research Centre, University of Leicester, Leicester Diabetes Centre, Leicester General Hospital, Leicester, UNITED KINGDOM; and 4NIHR Collaborations for Leadership in Applied Health Research and Care (CLAHRC), Leicester, UNITED KINGDOM.
Abstract
PURPOSE: In recent years, there has been a migration toward the use of glycated hemoglobin (HbA1c) in determining glycemic control. This study aimed to quantify the associations between changes in body weight, sedentary time, and moderate to vigorous physical activity (MVPA) time with HbA1c levels for a 3-yr period among adults at high risk of type 2 diabetes. METHODS: This study reports baseline and 3-yr follow-up data from the Walking Away from Type 2 Diabetes study. ActiGraph GT3X accelerometers captured sedentary time and MVPA. Linear regression examined the independent associations of changes in sedentary time, MVPA, and body weight with HbA1c between baseline and 3-yr follow-up. RESULTS: The sample composed of 489 participants (mean age = 64.2 ± 7.3 yr, body mass index = 31.7 ± 5.1, 63.4% male) with valid baseline and follow-up accelerometer, body weight, and HbA1c data. After adjustment for known confounders, an increase in MVPA time (per 30 min·d) was associated with a decrease in HbA1c percentage (β = -0.11 [-0.18 to -0.05], P = 0.001), and an increase in body weight (per 6 kg) was associated with an increase in HbA1c percentage (β = 0.08 [0.04-0.12], P < 0.001). The presence of dysglycemia at baseline (HbA1c ≥ 6.0%) strengthened these associations (P < 0.001 for interactions). Change in sedentary time was not significantly associated with change in HbA1c after adjustment for change in MVPA time. CONCLUSION: Increases in MVPA and body weight were associated with a reduction and increase in HbA1c, respectively, particularly in those with dysglycemia. Quantifying the effect that health behavior changes have on HbA1c can be used to inform prevention programs.
PURPOSE: In recent years, there has been a migration toward the use of glycated hemoglobin (HbA1c) in determining glycemic control. This study aimed to quantify the associations between changes in body weight, sedentary time, and moderate to vigorous physical activity (MVPA) time with HbA1c levels for a 3-yr period among adults at high risk of type 2 diabetes. METHODS: This study reports baseline and 3-yr follow-up data from the Walking Away from Type 2 Diabetes study. ActiGraph GT3X accelerometers captured sedentary time and MVPA. Linear regression examined the independent associations of changes in sedentary time, MVPA, and body weight with HbA1c between baseline and 3-yr follow-up. RESULTS: The sample composed of 489 participants (mean age = 64.2 ± 7.3 yr, body mass index = 31.7 ± 5.1, 63.4% male) with valid baseline and follow-up accelerometer, body weight, and HbA1c data. After adjustment for known confounders, an increase in MVPA time (per 30 min·d) was associated with a decrease in HbA1c percentage (β = -0.11 [-0.18 to -0.05], P = 0.001), and an increase in body weight (per 6 kg) was associated with an increase in HbA1c percentage (β = 0.08 [0.04-0.12], P < 0.001). The presence of dysglycemia at baseline (HbA1c ≥ 6.0%) strengthened these associations (P < 0.001 for interactions). Change in sedentary time was not significantly associated with change in HbA1c after adjustment for change in MVPA time. CONCLUSION: Increases in MVPA and body weight were associated with a reduction and increase in HbA1c, respectively, particularly in those with dysglycemia. Quantifying the effect that health behavior changes have on HbA1c can be used to inform prevention programs.
Authors: David E Laaksonen; Jaana Lindström; Timo A Lakka; Johan G Eriksson; Leo Niskanen; Katja Wikström; Sirkka Aunola; Sirkka Keinänen-Kiukaanniemi; Mauri Laakso; Timo T Valle; Pirjo Ilanne-Parikka; Anne Louheranta; Helena Hämäläinen; Merja Rastas; Virpi Salminen; Zygimantas Cepaitis; Martti Hakumäki; Hannu Kaikkonen; Pirjo Härkönen; Jouko Sundvall; Jaakko Tuomilehto; Matti Uusitupa Journal: Diabetes Date: 2005-01 Impact factor: 9.461
Authors: T Yates; C L Edwardson; J Henson; L J Gray; N B Ashra; J Troughton; K Khunti; M J Davies Journal: Diabet Med Date: 2016-10-19 Impact factor: 4.359
Authors: Joseph Henson; Melanie J Davies; Danielle H Bodicoat; Charlotte L Edwardson; Jason M R Gill; David J Stensel; Keith Tolfrey; David W Dunstan; Kamlesh Khunti; Thomas Yates Journal: Diabetes Care Date: 2015-12-01 Impact factor: 19.112
Authors: Elizabeth Selvin; Michael W Steffes; Hong Zhu; Kunihiro Matsushita; Lynne Wagenknecht; James Pankow; Josef Coresh; Frederick L Brancati Journal: N Engl J Med Date: 2010-03-04 Impact factor: 91.245
Authors: Jaana Lindström; Anne Louheranta; Marjo Mannelin; Merja Rastas; Virpi Salminen; Johan Eriksson; Matti Uusitupa; Jaakko Tuomilehto Journal: Diabetes Care Date: 2003-12 Impact factor: 19.112
Authors: Eivind Andersen; Hidde P van der Ploeg; Willem van Mechelen; Cindy M Gray; Nanette Mutrie; Femke van Nassau; Judith G M Jelsma; Annie S Anderson; Marlene N Silva; Hugo V Pereira; Alex McConnachie; Naveed Sattar; Marit Sørensen; Øystein B Røynesdal; Kate Hunt; Glyn C Roberts; Sally Wyke; Jason M R Gill Journal: Int J Behav Nutr Phys Act Date: 2021-12-20 Impact factor: 6.457
Authors: Zixin Zeng; Yuqian Bian; Yiran Cui; Donghui Yang; Yafeng Wang; Chuanhua Yu Journal: Int J Environ Res Public Health Date: 2020-10-25 Impact factor: 3.390
Authors: Kamlesh Khunti; Tom Yates; Simon Griffin; Alan Brennan; Helen Dallosso; Melanie J Davies; Helen C Eborall; Charlotte L Edwardson; Laura J Gray; Wendy Hardeman; Laura Heathcote; Joe Henson; Daniel Pollard; Stephen J Sharp; Stephen Sutton; Jacqui Troughton Journal: BMC Med Date: 2021-06-03 Impact factor: 8.775